SCHEMBL6653396

SCHEMBL6653396

CCOc1cccc(OC(C)=O)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.59
CYP3A4 P08684 2/20 0.59
MAPK1 P28482 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
ACHE P22303 1/20 0.54
TP53 P04637 1/20 0.52
KDM4E B2RXH2 4/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
ALDH1A1 P00352 2/20 0.51
RXRA P19793 1/20 0.51
RXRB P28702 1/20 0.51
MAPT P10636 2/20 0.51
KMT2A Q03164 5/20 0.50
MEN1 O00255 4/20 0.47
ACACB O00763 1/20 0.47
ACACA Q13085 1/20 0.47
HSD17B10 Q99714 2/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
ALOX12 P18054 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17028900 0.86 LMNA (0.76) LMNACYP3A4ACHETP53KDM4E
SCHEMBL249305 0.86 LMNA (0.76) LMNACYP3A4ACHETP53KDM4E
SCHEMBL9692573 0.86 KMT2A (0.61) LMNACYP3A4MAPK1L3MBTL1ACHE
SCHEMBL5737221 0.84 PLA2G4B (0.56) LMNACYP3A4MAPK1L3MBTL1ACHE
SCHEMBL27741955 0.84 ACHE (0.61) LMNACYP3A4MAPK1L3MBTL1ACHE
SCHEMBL10891338 0.83 TP53 (0.50) LMNACYP3A4MAPK1L3MBTL1TP53
SCHEMBL1196100 0.83 PLA2G4B (0.58) LMNACYP3A4KMT2A
SCHEMBL14341656 0.82 LMNA (0.56) LMNACYP3A4ACHETP53SMN1; SMN2
SCHEMBL4679397 0.82 LMNA (0.70) LMNACYP3A4MAPK1ACHEALOX15
Ethylene SCHEMBL28866733 0.82 LMNA (0.70) LMNACYP3A4MAPK1ACHETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762188-B1 INHIBITING THYMIDYLATE SYNTHASE; COLON, BREAST OR LUNG CARCINOMA SMITHKLINE BEECHAM CORPORATION 2004-07-13 US disclosed
EP-1199307-B1 Pharmaceutically active benzoquinazoline compounds WELLCOME FOUND (GB) 2004-02-25 EP disclosed
EP-1199307-A1 Pharmaceutically active benzoquinazoline compounds THE WELLCOME FOUNDATION LIMITED (GB) 2002-04-24 EP disclosed
US-6306865-B1 SYNTHASE INHIBITORS AND ANTITUMOR AGENTS GLAXO WELLCOME INC. 2001-10-23 US disclosed
US-6090941-A Pharmaceutically active benzoquinazoline compounds GLAXO WELLCOME INC. (US) 2000-07-18 US disclosed
US-5663337-A ENZYME, ANTITUMOR GLAXO WELLCOME INC. (US) 1997-09-02 US disclosed
US-5661155-A THYMIDYLATE SYNTHASE INHIBITOR; ADMINISTERING TO THE MAMMAL SUFFERING FROM LEUKEMIA OR TUMOR 2-(5-(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLINE-9-YL) METHYL)AMINO)-1-OXO-2-ISOINDOLINYL)GLUTARIC ACID OR SALTS GLAXO WELLCOME INC. (US) 1997-08-26 US disclosed
US-5405851-A Administering benzoquinazoline thymidylate synthase inhibitors BURROUGHS WELLCOME CO. (US) 1995-04-11 US disclosed
EP-0535034-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1993-04-07 EP disclosed
WO-1991019700-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1991-12-26 WO disclosed